35 Equity and ETF Scripts Long Term Growth Portfolio | MarketCap – Mid Cap 150 | Rebalancing Monthly | AllETFs Composition is 20% | 12 Months Subscription Plan

₹66,875.00 for 1 year

Telegram Bot Command for @ShubhaangBot : /md150_35_2675000_t_20

Portfolio Parameters

Parameter	Value
Scripts Group Title	MarketCap – Mid Cap 150
Portfolio Size	35 Equity and ETF Scripts {28 Equities and 7 All ETFs}
ETFs Composition Percentage	AllETFs Composition is 20%
Portfolio Risk	Future Risk may Exceed 45%
Minimum Annual Investment Capital	₹ 26,75,000
Optimal Investment Tenure	9 or more years.
Rebalancing Frequency	Rebalancing Monthly
Subscription Tenure	12 Months Subscription Plan
Backtest – Sharpe Ratio	Hist. Sharpe Ratio above 1.6
Backtest – Annualised Returns	Hist. Annualised Returns Under 45%
Backtest – Annualised Risk	Hist. Annualised Risk Exceeding 20%
Backtest – Max. Drawdown	Hist. Max. Drawdown Exceeding 20%
Backtest – Max. Recovery Time	Hist. Max. Recovery Time Exceeding 5 Quarters
Simulation – Lumpsum Capital Growth Multiple	** More than 140 times in 20 yrs with 99.9% probability

Probability Levels (%)	20 Years	15 Years	10 Years	5 Years	3 Years	1 Year
99.9% Probability	** 140.02	29.16	6.43	1.65	1.04	0.76
99% Probability	283.65	53.33	10.62	2.35	1.37	0.90
98% Probability	365.24	66.32	12.69	2.66	1.51	0.95
95% Probability	533.43	92.21	16.57	3.22	1.75	1.03
90% Probability	751.24	123.95	21.06	3.81	1.99	1.11
80% Probability	1,155.14	179.22	28.40	4.69	2.34	1.22
75% Probability	1,371.52	207.55	31.96	5.09	2.49	1.27
50% Probability	3,792.99	482.95	61.57	7.84	3.44	1.51

Refer to the “Backtests & Simulations” tab for further details on their operational settings.

Invest in leading mid-cap stocks known for solid earnings growth and market influence.

Higher Growth Potential: India’s midcap stocks are expected to grow at a CAGR of around 13-15%, offering the opportunity for significantly higher returns compared to fixed income or large-cap equities.
Undervalued and Emerging Opportunities: Midcap stocks often represent emerging companies with strong growth prospects that are undervalued or overlooked by the broader market, providing superior upside potential.
Diversification and Risk-Reward Balance: Investing in midcap stocks offers a balanced risk-reward profile, capturing the benefits of potential high growth while diversifying beyond traditional asset classes like bonds or developed market equities.

Universe Definition: The investment universe encompasses securities from listed companies within the NSE 500 Index and all exchange-traded funds (ETFs), which are rigorously filtered based on qualitative measures aligned with predefined investment objectives and rationales.
Systematic Identification: Proprietary algorithms, advanced quantitative models, and technical analysis are utilized to systematically identify securities with a high probability of delivering superior returns.
Data-Driven Framework: These models, thoroughly validated across diverse asset classes and various time horizons, integrate customized proprietary indicators such as momentum, volume, volatility, and trend analysis. This approach ensures that the portfolio construction process is entirely based on objective data and high-quality signals, devoid of biases, prejudices, or emotional factors.
Optimisation of Security Selection: The selection of securities and their corresponding weightings within the Equity/ETF portfolio are further refined based on critical factors, including target portfolio size, ETF allocation, average daily trading turnover, available investment capital, rebalancing frequency, and the number of quantitative and technical criteria met by each security.

Backtest models are constructed using a limited set of assumptions about market conditions and portfolio characteristics; therefore, backtest results should not be interpreted as indicative of actual past performance in real-world conditions.
Backtest results and Simulation results should never be used as a basis for comparing the actual performance of other intermediaries.
Backtest and simulation outputs are provided solely as factual data to support comparative assessment of my subscription plans. They highlight the model’s potential in relation to the portfolio’s investment rationale and parameters under the stated investment methodology.
Simulation results are derived from 10,00,000 trials and represent potential future scenarios based on normalised inputs (average returns and return volatility) obtained from backtesting.
Users are strongly advised to exercise extreme caution when using this information.
These back-test results and simulation have not been verified by PaRRVA (Past Risk and Return Verification Agency) or any other SEBI-recognized agency.
The impact of periodic portfolio rebalancing and transaction costs has been factored into these back-test results.
"Backtesting and simulation results do not serve as indicators of future performance or guarantees of returns and they should not be interpreted as an endorsement or advertisement."

Monthly Portfolio Returns are assumed to follow a normal distribution over a 20-year horizon, with mean returns and volatility presumed to mirror historically observed levels.
Portfolios are rebalanced once monthly.
Portfolio risk level and Sharpe ratio are assumed to remain unchanged over the 20-year period.
Other than the initial lump sum investment, no additional contributions or withdrawals are made over the 20 years period.
Portfolio rebalancing is assumed to be unconstrained by liquidity over the 20‑year period: required quantities of each security can be bought or sold at competitive prices on every rebalancing, and transaction volumes are assumed to have a negligible impact on market prices.
Earnings from dividends are ignored.
Simulation results are not adjusted for inflation rates.
Effects of taxes on the capital appreciation (Capital Gains Tax & Taxes on Dividends) are not accounted.

Transactional costs are included in the Sharpe ratio calculations.
Risk free rate is assumed to be 6.5% p.a.
Each simulation value is resulted from 10,00,000 simulation trials using the Monte Carlo method.
Simulation results are derived for probability levels (confidence levels) of 99.9%, 99%, 98%, 95%, 90%, 80%, 75%, and 50%.
Simulation values do not predict or reflect future market conditions; they represent only possible future outcomes.